Trial ID or NCT#
NCT00822900
Status
NOT RECRUITING
Purpose
The ProTECT study will determine if intravenous (IV) progesterone (started within 4 hours of injury and given for a total of 96 hours), is more effective than placebo for treating victims of moderate to severe acute traumatic brain injury.
Official Title
Phase 3 Clinical Trial to Determine if Progesterone Along With Standard Medical Care for Brain Injury is More Effective at Limiting the Amount of Damage Cause by a Traumatic Brain Injury Than Standard Medical Care Alone.
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
James Quinn
Emergency medicine doctor,
Pediatric emergency medicine doctor
Professor of Emergency Medicine
Chitra Venkatasubramanian, MBBS, MD
Neurocritical care specialist,
Stroke and vascular neurologist
Clinical Professor, Neurology & Neurological Sciences
Anna Finley Caulfield, MD
Neurocritical care specialist
Clinical Associate Professor, Neurology & Neurological Sciences
Contact us to find out if this trial is right for you.
CONTACT
Rosen Mann
(650) 721-2645
View on ClinicalTrials.gov